Login / Signup
TP53 Gene Polymorphism at Codon 72 as a Response Predictor for Neoadjuvant Chemotherapy.
Jussane Oliveira Vieira
João Bosco Pesquero
Afonso Celso Pinto Nazário
Published in:
Breast care (Basel, Switzerland) (2024)
polymorphism at codon 72 is not a predictor of pCR, but it can be a predictor of stable disease.
Keyphrases
</>
neoadjuvant chemotherapy
locally advanced
lymph node
sentinel lymph node
squamous cell carcinoma